CP
STLN

CenterBook Partners’s Starling Oncology STLN Stock Holding History

CenterBook Partners’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Sell
1,241,660
-326,763
-21% -$1.37M 0.33% 69
2026
Q1 		$4.82M Sell
1,568,423
-1,460,889
-48% -$4.48M 0.26% 106
2025
Q4 		$10.8M Buy
3,029,312
+324,662
+12% +$1.2M 0.53% 38
2025
Q3 		$9.44M Buy
2,704,650
+1,988,751
+278% +$6.81M 0.47% 44
2025
Q2 		$1.47M Buy
+715,899
New +$1.79M 0.08% 280

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CenterBook Partners's STLN Position: Q2 2026 in Review

CenterBook Partners reduced its Starling Oncology (STLN) stake by 21% in Q2 2026, selling an estimated $1.37M and leaving 1,241,660 shares worth $6.74M. The position accounts for 0.33% of the portfolio, ranked #69.

CenterBook Partners first reported a position in STLN in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.8M in Q4 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • CenterBook Partners held 1,241,660 shares of Starling Oncology worth $6.74M as of Q2 2026.
  • CenterBook Partners sold 326,763 Starling Oncology shares in Q2 2026, an estimated $1.37M.
  • Starling Oncology made up 0.33% of CenterBook Partners's portfolio in Q2 2026, its #69 holding.
  • CenterBook Partners first reported a position in Starling Oncology in Q2 2025 and has held it in 5 quarters since.
  • CenterBook Partners's Starling Oncology position peaked at $10.8M in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.